Cytosorbents (CTSO) News Today $1.04 +0.01 (+0.97%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$1.02 -0.02 (-1.92%) As of 03/25/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.comStockNews.com started coverage on Cytosorbents in a research note on Wednesday. They set a "hold" rating for the company.March 26 at 2:17 AM | marketbeat.comCytosorbents (CTSO) Expected to Announce Quarterly Earnings on MondayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Monday, March 31, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=670228)March 24 at 2:26 AM | marketbeat.comCytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual AuditMarch 21, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average - Here's WhyCytosorbents (NASDAQ:CTSO) Stock Price Passes Above Two Hundred Day Moving Average - Here's WhyMarch 18, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years agoMarch 10, 2025 | uk.finance.yahoo.comStockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)StockNews.com began coverage on shares of Cytosorbents in a research note on Monday. They set a "hold" rating on the stock.March 10, 2025 | marketbeat.comCytoSorbents reiterates Q4 product revenue view $9M-$9.2MMarch 4, 2025 | markets.businessinsider.comCytoSorbents postpones earnings release to allow time for annual auditMarch 4, 2025 | markets.businessinsider.comCytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate ControllerMarch 4, 2025 | globenewswire.comCytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.comStockNews.com started coverage on Cytosorbents in a research report on Sunday. They set a "hold" rating on the stock.March 2, 2025 | marketbeat.comCytosorbents Corp. CTSO (U.S.: Nasdaq)February 27, 2025 | wsj.comCytosorbents (CTSO) to Release Quarterly Earnings on ThursdayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Thursday, March 6, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=670228)February 27, 2025 | marketbeat.comCytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsFebruary 27, 2025 | finance.yahoo.comCytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $10.00 price objective on shares of Cytosorbents in a research note on Tuesday.February 25, 2025 | marketbeat.comCytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right WarrantsFebruary 25, 2025 | finance.yahoo.comCytosorbents Co. (NASDAQ:CTSO) Short Interest UpdateCytosorbents Co. (NASDAQ:CTSO - Get Free Report) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 1,930,000 shares, an increase of 5.5% from the January 15th total of 1,830,000 shares. Based on an average daily trading volume, of 257,900 shares, the days-to-cover ratio is presently 7.5 days.February 18, 2025 | marketbeat.comCTSO stock touches 52-week high at $1.6 amid robust annual growthFebruary 14, 2025 | msn.comCytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?Cytosorbents (NASDAQ:CTSO) Stock Crosses Above 200-Day Moving Average - Here's What HappenedFebruary 14, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.comStockNews.com began coverage on shares of Cytosorbents in a research note on Friday. They issued a "hold" rating on the stock.February 14, 2025 | marketbeat.comSargent Investment Group LLC Decreases Stake in Cytosorbents Co. (NASDAQ:CTSO)Sargent Investment Group LLC trimmed its position in Cytosorbents Co. (NASDAQ:CTSO - Free Report) by 23.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,248,863 shares of the medicalFebruary 5, 2025 | marketbeat.comCytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short InterestCytosorbents Co. (NASDAQ:CTSO - Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,830,000 shares, an increase of 26.2% from the December 31st total of 1,450,000 shares. Based on an average daily trading volume, of 262,700 shares, the short-interest ratio is currently 7.0 days.February 1, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Stock Crosses Above Two Hundred Day Moving Average - Here's What HappenedCytosorbents (NASDAQ:CTSO) Stock Price Crosses Above 200-Day Moving Average - What's Next?January 29, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.comStockNews.com assumed coverage on shares of Cytosorbents in a report on Wednesday. They set a "hold" rating for the company.January 29, 2025 | marketbeat.comCytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights OfferingJanuary 13, 2025 | markets.businessinsider.comExpert Outlook: CytoSorbents Through The Eyes Of 7 AnalystsJanuary 13, 2025 | benzinga.comCytoSorbents closes oversubscribed rights offeringJanuary 13, 2025 | msn.comCytosorbents' (CTSO) "Buy" Rating Reaffirmed at D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $10.00 price objective on shares of Cytosorbents in a research note on Monday.January 13, 2025 | marketbeat.comCytoSorbents opens regional sales subsidiary in DubaiJanuary 6, 2025 | markets.businessinsider.comCytoSorbents sees Q4 product revenue $9M-$9.2M vs. $7.35M last yearJanuary 5, 2025 | markets.businessinsider.comCytoSorbents reported strong Q4 results, says D. Boral CapitalJanuary 4, 2025 | finance.yahoo.comCTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.January 3, 2025 | msn.comCytoSorbents Sees Higher Product Revenue, Weak Margin In Q4; Stock DownJanuary 3, 2025 | markets.businessinsider.comCytoSorbents sees Q4 product revenue growth of 22%-25% Y/YJanuary 3, 2025 | msn.comCytosorbents' (CTSO) Buy Rating Reiterated at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $10.00 target price on shares of Cytosorbents in a report on Friday.January 3, 2025 | marketbeat.comCytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product RevenueJanuary 3, 2025 | globenewswire.comCytoSorbents commences Rights OfferingDecember 24, 2024 | markets.businessinsider.comCytosorbents Co. (NASDAQ:CTSO) CFO Peter J. Mariani Purchases 20,000 SharesDecember 17, 2024 | insidertrades.comCytosorbents Co. (NASDAQ:CTSO) CFO Peter J. Mariani Acquires 20,000 SharesCytosorbents Co. (NASDAQ:CTSO - Get Free Report) CFO Peter J. Mariani acquired 20,000 shares of the firm's stock in a transaction on Friday, December 13th. The stock was purchased at an average price of $0.96 per share, for a total transaction of $19,200.00. Following the completion of the transaction, the chief financial officer now directly owns 401,363 shares in the company, valued at approximately $385,308.48. The trade was a 5.24 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 16, 2024 | marketbeat.comInsider Buying: Cytosorbents Co. (NASDAQ:CTSO) CFO Buys 11,363 Shares of StockDecember 14, 2024 | insidertrades.comCTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available LiquidityDecember 12, 2024 | msn.comCytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference WeekDecember 12, 2024 | globenewswire.comCytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare ConferenceNovember 26, 2024 | finance.yahoo.comCytosorbents FY2024 EPS Forecast Reduced by HC WainwrightCytosorbents Co. (NASDAQ:CTSO - Free Report) - Stock analysts at HC Wainwright decreased their FY2024 earnings per share estimates for shares of Cytosorbents in a research note issued to investors on Monday, November 11th. HC Wainwright analyst S. Lee now expects that the medical research companyNovember 14, 2024 | marketbeat.comCytoSorbents, Converge Biotech announce strategic partnershipNovember 12, 2024 | markets.businessinsider.comCytoSorbents Hops on Alliance with ConvergeNovember 11, 2024 | baystreet.caBalanced Hold Rating Amid Revenue Miss and Strategic Initiatives at CytoSorbentsNovember 11, 2024 | markets.businessinsider.comCytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in IndiaNovember 11, 2024 | globenewswire.comCytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of Cytosorbents in a research note on Sunday. They issued a "hold" rating on the stock.November 10, 2024 | marketbeat.comCytosorbents Corporation (CTSO) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comCytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ...November 9, 2024 | finance.yahoo.com Remove Ads Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address CTSO Media Mentions By Week CTSO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼0.610.79▲Average Medical News Sentiment CTSO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼31▲CTSO Articles Average Week Remove Ads Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVRO News Today ELMD News Today PROF News Today LAKE News Today INGN News Today DRTS News Today AVR News Today BWAY News Today SKIN News Today OBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
